Marta Gargallo-Alonso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marta Gargallo-Alonso has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Ibáñez-Deler
Aragón Biomedical Research Center (CIBA) Aragon Institute of Health Sciences (IACS) 50009 Zaragoza Spain
2 shared publicationsClara Malo
Aragón Engineering Research Institute (I3A) Tissue Microenvironment (TME) Lab Revista "Jornada de Jóvenes Investigadores del I3A" University of Zaragoza Mariano Esquillor s/n 50018 Zaragoza Spain
2 shared publicationsLara Pancorbo
BEONChip CEMINEM 50018 Zaragoza Spain
2 shared publicationsMaría Royo-Cañas
Aragón Biomedical Research Center (CIBA) Aragon Institute of Health Sciences (IACS) 50009 Zaragoza Spain
2 shared publicationsPaula Chueca
Biotechnology Undergraduate Student University of Zaragoza 50009 Zaragoza Spain
2 shared publications- Clara Malo
Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, 50018 Zaragoza, Spain
1 shared publication
Latest Publications
- Open Access
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 5
Advances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes
The in vitro maturation (IVM) of human oocytes represents a valuable assisted reproductive technology that bypasses the need for full ovarian stimulation, offering safer alternatives for patients with polycystic ovary syndrome (PCOS), resistant ovary syndrome, or those requiring fertility preservation before oncological treatment. Despite its potential, IVM efficiency remains lower than that of conventional in vitro fertilization (IVF) due to incomplete understanding of the molecular and metabolic mechanisms underpinning oocyte maturation. This review summarizes recent advances in IVM, including biphasic or simulated physiological oocyte maturation (SPOM) systems, optimization of culture media through hormones, growth factors, and antioxidants, and the influence of cumulus–oocyte communication on developmental competence. We also discuss the biochemical regulation of meiosis, metabolic interactions, and gene expression patterns associated with oocyte quality. Furthermore, we examine the translational and clinical applications of IVM in human fertility treatment, highlighting its efficacy in PCOS and oncofertility cases, and the limitations that persist in replicating in vivo conditions. Emerging technologies such as microfluidic and three-dimensional culture systems show promise in enhancing oocyte competence and embryo yield. Continued research into the molecular mechanisms governing oocyte maturation will be key to improving IVM outcomes and integrating this approach as a mainstream option in reproductive medicine.
- 19 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 5
Open AccessAdvances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes
The in vitro maturation (IVM) of human oocytes represents a valuable assisted reproductive technology that bypasses the need for full ovarian stimulation, offering safer alternatives for patients with polycystic ovary syndrome (PCOS), resistant ovary syndrome, or those requiring fertility preservation before oncological treatment. Despite its potential, IVM efficiency remains lower than that of conventional in vitro fertilization (IVF) due to incomplete understanding of the molecular and metabolic mechanisms underpinning oocyte maturation. This review summarizes recent advances in IVM, including biphasic or simulated physiological oocyte maturation (SPOM) systems, optimization of culture media through hormones, growth factors, and antioxidants, and the influence of cumulus–oocyte communication on developmental competence. We also discuss the biochemical regulation of meiosis, metabolic interactions, and gene expression patterns associated with oocyte quality. Furthermore, we examine the translational and clinical applications of IVM in human fertility treatment, highlighting its efficacy in PCOS and oncofertility cases, and the limitations that persist in replicating in vivo conditions. Emerging technologies such as microfluidic and three-dimensional culture systems show promise in enhancing oocyte competence and embryo yield. Continued research into the molecular mechanisms governing oocyte maturation will be key to improving IVM outcomes and integrating this approach as a mainstream option in reproductive medicine.
- Open Access
- 28 July 2025
- Published by Universidad de Zaragoza in Jornada de Jóvenes Investigadores del I3A
- Vol. 13
Marta Gargallo - Effect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
Effect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
- 28 July 2025
- Published by Universidad de Zaragoza in Jornada de Jóvenes Investigadores del I3A
- Vol. 13
Open AccessMarta Gargallo - Effect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
Effect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
- Open Access
- 28 July 2025
- Published by Universidad de Zaragoza in Jornada de Jóvenes Investigadores del I3A
- Vol. 13
Effect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
This study aimed to assess the impact of different tissue sectioning techniques and transport temperatures on the structural integrity of ovarian tissue. Two primary variables were evaluated: the sectioning method (manual, non-rough surface tool, rough surface tool, and vibratome) and the transport temperature (5°C, 20°C, and 37°C).
- 28 July 2025
- Published by Universidad de Zaragoza in Jornada de Jóvenes Investigadores del I3A
- Vol. 13
Open AccessEffect of the Cutting Method and Transport Temperature on the Quality of Ovarian Tissue
This study aimed to assess the impact of different tissue sectioning techniques and transport temperatures on the structural integrity of ovarian tissue. Two primary variables were evaluated: the sectioning method (manual, non-rough surface tool, rough surface tool, and vibratome) and the transport temperature (5°C, 20°C, and 37°C).